Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indigo naturalis for autoimmune pancreatitis
jRCTs051210171Completed
- Sponsor
- Keio University
- Start
- Feb 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial of indigo naturalis in autoimmune pancreatitis (AIP), sponsored by Keio University. Primary endpoint: Safety during the study. Started Feb 2022; status: completed.
02
Drugs
indigo naturalis
03
Conditions
autoimmune pancreatitis (AIP)
Beyond the preview
Go deeper on jRCTs051210171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210171.